GATK takes 6 hours.
SeqSwift takes 0.007 seconds.

No child, anywhere, should die because a genomic result took days instead of seconds.

Request Access → View Release
2.88s
103 MinION files
0.007s
HPV16/18 panel
489 MB
Peak RAM
$140
Chromebook. No cloud.

⚡ Benchmarks

Use CaseSeqSwiftTraditionalHardware
E. coli AMR (103 MinION files)2.88 seconds24–72 hours$140 Chromebook
HPV16/18 Oncology0.007 seconds4–8 hoursAny laptop
Sickle Cell (1,000 patients)~2 secondsHoursLow-end device
Full GRCh38 build25 minutesGPU cluster requiredChromebook
Peak RAM usage489 MB16–64 GB typicalAny device

🔬 Available Pilots

🦠 E. coli AMR / Sepsis

gyrA S83L · parC S80I · fluoroquinolone resistance detection

🧬 HPV16/18 Oncology

Sub-millisecond cervical cancer screening · point-of-care ready

🧬 Sickle Cell (HBB)

HbS mutation detection · 1,000 patients in ~2 seconds

🔬 NK Cell Attenuation

Immunotherapy support panel · alignment-free k-mer detection

🌍 GRCh38 Full Human

3.1B bases · 739 MB index · Chr22 in 58s · fully offline

🦠 SARS-CoV-2

Rapid variant detection · air-gapped deployment ready

All pilots GPG-encrypted · Patent-pending (63/187,188) · Runs 100% offline

💰 Pricing

Academic & Non-Profit

Free / forever
For researchers, universities, and NGOs advancing global health.
  • All available pilots
  • GPG-encrypted panel files
  • Full offline deployment
  • Community support via GitHub
  • Commercial use
  • SLA or dedicated support
Request Access →

Enterprise / OEM

Custom partnership
For sequencing platform vendors and global health organizations.
  • Full source license
  • Custom panel development
  • OEM integration support
  • Co-development available
  • Dedicated SLA
  • White-label options
Discuss Partnership →

📧 Get Started

Ready to evaluate SeqSwift? Here's how it works:

1Download the encrypted pilot from the GitHub release
2Email david@seqswift.com with your use case and institution
3Receive your GPG passphrase directly — no bots, no forms
4Decrypt and run on any Linux/ChromeOS/macOS/WSL device
Email david@seqswift.com →

🌱 Why We Built This

During a family-medicine clerkship, the young daughter of his preceptor died of an overwhelming infection that rapid diagnostics might have caught sooner. Close friends from Kenya lost patients to late-diagnosed sepsis and resistant pathogens.

No big lab. No big budget.
Just code that refuses to let the next child wait.

Dave Schliemann, MD

Founder & CEO

Physician and systems programmer (MIT 6.001x). Built sub-second bedside sequencing that runs on a $140 edge device — in a Level-I trauma bay or a rural Kenyan ward. Patent-pending (63/187,188).

Dr. Boss Opiyo, MD

VP, Global Partnerships

Medical resident at UNC Greenville with UN-level global health experience. Bridges cutting-edge genomic technology and real-world deployment in resource-limited settings across Sub-Saharan Africa.